Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Utah Medical Products Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
110
+10 vs. Q2 2024
Shares held
2.41M
+183.7K (+8.3%) vs. Q2 2024
Total value
$161.2M
+$12.2M (+8.2%) vs. Q2 2024
New holders
19
43 more added
Sold out
9
26 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting UTMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 110 institutions
Q1 2021: 79 institutionsQ2 2021: 68 institutionsQ3 2021: 72 institutionsQ4 2021: 79 institutionsQ1 2022: 85 institutionsQ2 2022: 75 institutionsQ3 2022: 78 institutionsQ4 2022: 82 institutionsQ1 2023: 87 institutionsQ2 2023: 90 institutionsQ3 2023: 92 institutionsQ4 2023: 89 institutionsQ1 2024: 100 institutionsQ2 2024: 101 institutionsQ3 2024: 110 institutionsQ4 2024: 112 institutionsQ1 2025: 110 institutionsQ2 2025: 112 institutionsQ3 2025: 117 institutionsQ4 2025: 117 institutionsQ1 2026: 120 institutionsQ2 2026: 115 institutions
Value heldQ3 2024: $161.2M
Q1 2021: $228.0MQ2 2021: $221.1MQ3 2021: $241.5MQ4 2021: $260.4MQ1 2022: $231.2MQ2 2022: $219.9MQ3 2022: $216.3MQ4 2022: $256.0MQ1 2023: $241.0MQ2 2023: $237.5MQ3 2023: $221.3MQ4 2023: $211.9MQ1 2024: $177.1MQ2 2024: $162.1MQ3 2024: $161.2MQ4 2024: $141.7MQ1 2025: $125.6MQ2 2025: $122.9MQ3 2025: $136.5MQ4 2025: $117.5MQ1 2026: $140.5MQ2 2026: $159.9M
Institutions holding UTMD and their total value by quarter
QuarterHoldersValue
Q2 2026115$159.9M
Q1 2026120$140.5M
Q4 2025117$117.5M
Q3 2025117$136.5M
Q2 2025112$122.9M
Q1 2025110$125.6M
Q4 2024112$141.7M
Q3 2024110$161.2M
Q2 2024101$162.1M
Q1 2024100$177.1M
Q4 202389$211.9M
Q3 202392$221.3M
Q2 202390$237.5M
Q1 202387$241.0M
Q4 202282$256.0M
Q3 202278$216.3M
Q2 202275$219.9M
Q1 202285$231.2M
Q4 202179$260.4M
Q3 202172$241.5M
Q2 202168$221.1M
Q1 202179$228.0M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Utah Medical Products Inc; share changes are against Q2 2024.

Institutions holding UTMD in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Rice Hall James & Associates, LLC83,338$5.58M0.30%+16,297+24.3%Added
Ranger Investment Management, L.P.86,554$5.79M0.37%+1,800+2.1%Added
Hotchkis & Wiley Capital Management LLC89,010$5.96M0.02%+50,030+128.3%Added
Geode Capital Management, LLC97,080$6.50M0.00%+8,516+9.6%Added
Brandes Investment Partners, LP138,365$9.26M0.10%+21,841+18.7%Added
Dimensional Fund Advisors LP175,504$11.7M0.00%+5,194+3.0%Added
BlackRock, Inc.180,095$12.1M0.00%+180,095New
Vanguard Group Inc181,169$12.1M0.00%+2,594+1.5%Added
Renaissance Technologies LLC230,614$15.4M0.02%+3,500+1.5%Added
FMR LLC268,823$18.0M0.00%−145,639−35.1%Reduced
Bank of Montreal0$00.00%−15,559−100.0%Sold out
Quadrature Capital Ltd0$00.00%−8,521−100.0%Sold out
Invesco Ltd.0$00.00%−6,650−100.0%Sold out
Penn Mutual Asset Management, LLC0$00.00%−6,298−100.0%Sold out
Sequoia Financial Advisors, LLC0$00.00%−4,597−100.0%Sold out
STRS Ohio0$00.00%−1,000−100.0%Sold out
Loomis Sayles & Co L P0$00.00%−330−100.0%Sold out
Innealta Capital, LLC0$00.00%−61−100.0%Sold out
Cornerstone Planning Group LLC0$00.00%−21−100.0%Sold out
BlackRock Inc.––––Not filed